By the same authors

From the same journal

From the same journal

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

Research output: Contribution to journalArticle

Standard

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. / Catalá-López, F.; Caulley, L.; Ridao, M.; Hutton, B.; Husereau, D.; Drummond, M. F.; Alonso-Arroyo, A.; Pardo-Fernández, M.; Bernal-Delgado, E.; Meneu, R.; Tabarés-Seisdedos, R.; Ramón Repullo, J.; Moher, D.

In: BMJ Open, Vol. 10, e034463, 14.02.2020.

Research output: Contribution to journalArticle

Harvard

Catalá-López, F, Caulley, L, Ridao, M, Hutton, B, Husereau, D, Drummond, MF, Alonso-Arroyo, A, Pardo-Fernández, M, Bernal-Delgado, E, Meneu, R, Tabarés-Seisdedos, R, Ramón Repullo, J & Moher, D 2020, 'Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis', BMJ Open, vol. 10, e034463. https://doi.org/10.1136/ bmjopen-2019-034463

APA

Catalá-López, F., Caulley, L., Ridao, M., Hutton, B., Husereau, D., Drummond, M. F., ... Moher, D. (2020). Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. BMJ Open, 10, [e034463]. https://doi.org/10.1136/ bmjopen-2019-034463

Vancouver

Catalá-López F, Caulley L, Ridao M, Hutton B, Husereau D, Drummond MF et al. Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. BMJ Open. 2020 Feb 14;10. e034463. https://doi.org/10.1136/ bmjopen-2019-034463

Author

Catalá-López, F. ; Caulley, L. ; Ridao, M. ; Hutton, B. ; Husereau, D. ; Drummond, M. F. ; Alonso-Arroyo, A. ; Pardo-Fernández, M. ; Bernal-Delgado, E. ; Meneu, R. ; Tabarés-Seisdedos, R. ; Ramón Repullo, J. ; Moher, D. / Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. In: BMJ Open. 2020 ; Vol. 10.

Bibtex - Download

@article{ae23b11a104c4c7b8238a6b7c46147bd,
title = "Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis",
abstract = "Introduction There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparativeanalysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles ofeconomic evaluations of healthcare interventions indexed in MEDLINE incorporate research practices that promote transparency, openness and reproducibility.Methods and analysis This is the study protocol for a cross-sectional comparative analysis. We registered the study protocol within the Open Science Framework ( osf.io/gzaxr). We will evaluate a random sample of 600cost-effectiveness analysis publications, a specific form of health economic evaluations, indexed in MEDLINE during 2012 (n=200), 2019 (n=200) and 2022 (n=200). We will include published papers written in English reporting an incremental cost-effectiveness ratio in terms of costs per life years gained, quality-adjusted life years and/or disability-adjusted life years. Screening and selection of articles will be conducted by at least two researchers. Reproducible research practices, openness and transparency in each article will be extracted using a standardised data extraction form by multiple researchers, with a 33{\%} random sample (n=200) extracted in duplicate.Information on general, methodological and reproducibility items will be reported, stratified by year, citation of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement and journal. Risk ratioswith 95{\%} CIs will be calculated to represent changes in reporting between 2012–2019 and 2019–2022.",
keywords = "Cost-effectiveness analysis, Data sharing, Methodology, Quality, Reporting, Reproducibility",
author = "F. Catal{\'a}-L{\'o}pez and L. Caulley and M. Ridao and B. Hutton and D. Husereau and Drummond, {M. F.} and A. Alonso-Arroyo and M. Pardo-Fern{\'a}ndez and E. Bernal-Delgado and R. Meneu and R. Tabar{\'e}s-Seisdedos and {Ram{\'o}n Repullo}, J. and D. Moher",
note = "{\circledC} Author(s) (or their employer(s)) 2020",
year = "2020",
month = "2",
day = "14",
doi = "10.1136/ bmjopen-2019-034463",
language = "English",
volume = "10",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "British Medical Journal Publishing Group",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

AU - Catalá-López, F.

AU - Caulley, L.

AU - Ridao, M.

AU - Hutton, B.

AU - Husereau, D.

AU - Drummond, M. F.

AU - Alonso-Arroyo, A.

AU - Pardo-Fernández, M.

AU - Bernal-Delgado, E.

AU - Meneu, R.

AU - Tabarés-Seisdedos, R.

AU - Ramón Repullo, J.

AU - Moher, D.

N1 - © Author(s) (or their employer(s)) 2020

PY - 2020/2/14

Y1 - 2020/2/14

N2 - Introduction There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparativeanalysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles ofeconomic evaluations of healthcare interventions indexed in MEDLINE incorporate research practices that promote transparency, openness and reproducibility.Methods and analysis This is the study protocol for a cross-sectional comparative analysis. We registered the study protocol within the Open Science Framework ( osf.io/gzaxr). We will evaluate a random sample of 600cost-effectiveness analysis publications, a specific form of health economic evaluations, indexed in MEDLINE during 2012 (n=200), 2019 (n=200) and 2022 (n=200). We will include published papers written in English reporting an incremental cost-effectiveness ratio in terms of costs per life years gained, quality-adjusted life years and/or disability-adjusted life years. Screening and selection of articles will be conducted by at least two researchers. Reproducible research practices, openness and transparency in each article will be extracted using a standardised data extraction form by multiple researchers, with a 33% random sample (n=200) extracted in duplicate.Information on general, methodological and reproducibility items will be reported, stratified by year, citation of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement and journal. Risk ratioswith 95% CIs will be calculated to represent changes in reporting between 2012–2019 and 2019–2022.

AB - Introduction There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparativeanalysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles ofeconomic evaluations of healthcare interventions indexed in MEDLINE incorporate research practices that promote transparency, openness and reproducibility.Methods and analysis This is the study protocol for a cross-sectional comparative analysis. We registered the study protocol within the Open Science Framework ( osf.io/gzaxr). We will evaluate a random sample of 600cost-effectiveness analysis publications, a specific form of health economic evaluations, indexed in MEDLINE during 2012 (n=200), 2019 (n=200) and 2022 (n=200). We will include published papers written in English reporting an incremental cost-effectiveness ratio in terms of costs per life years gained, quality-adjusted life years and/or disability-adjusted life years. Screening and selection of articles will be conducted by at least two researchers. Reproducible research practices, openness and transparency in each article will be extracted using a standardised data extraction form by multiple researchers, with a 33% random sample (n=200) extracted in duplicate.Information on general, methodological and reproducibility items will be reported, stratified by year, citation of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement and journal. Risk ratioswith 95% CIs will be calculated to represent changes in reporting between 2012–2019 and 2019–2022.

KW - Cost-effectiveness analysis

KW - Data sharing

KW - Methodology

KW - Quality

KW - Reporting

KW - Reproducibility

U2 - 10.1136/ bmjopen-2019-034463

DO - 10.1136/ bmjopen-2019-034463

M3 - Article

VL - 10

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

M1 - e034463

ER -